查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930057

全球下一代定序市場：市場規模、佔有率、成長率、產業分析、按類型、應用和地區劃分的分析以及未來預測（2025-2034）

Next-Generation Sequencing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 202 Pages | 商品交期: 請詢問到貨日

價格

次世代定序 (NGS) 市場成長驅動因子

預計全球次世代定序 (NGS) 市場規模在 2025 年將達到 104.4 億美元，並在 2026 年達到 117.9 億美元。預計到 2034 年將進一步成長至 383.4 億美元，預測期內複合年增長率 (CAGR) 為 15.88%。北美地區在 2025 年將以 56.01% 的市佔率領先，這主要得益於先進的研究基礎設施、大量的研發投資、在臨床和研究領域積極採用基因組學技術，以及 Illumina、Thermo Fisher Scientific 和 PacBio 等主要廠商的存在。

次世代定序 (NGS) 是一項革命性的技術，能夠實現高通量、可擴展且快速的 DNA 定序，從而變革基因組研究和臨床診斷。其應用涵蓋基因檢測、非侵入性產前檢測、腫瘤學、傳染病監測和個人化醫療等領域。 COVID-19 疫情加速了 NGS 的普及，其在 SARS-CoV-2 病毒的研究、監測和測序中的應用，刺激了疫苗研發的研究活動和投資。

主要市場驅動因子

診斷和研究領域的多元化應用：NGS 成本的下降和準確性的提高，正在拓展其在診斷領域的應用，包括癌症篩檢、生殖醫學、遺傳疾病檢測和伴隨診斷。例如，賽默飛世爾科技和拜耳於 2024 年 3 月合作開發基於 NGS 的伴隨診斷檢測方法，以支援臨床研發。

技術進步與產品創新：儀器和耗材的持續創新正在提升定序速度、準確性和數據分析能力。 2022年6月，PerkinElmer推出了BioQule NGS系統，這是一款自動化桌上型解決方案；2023年3月，Illumina推出了Connected Insights，這是一款基於雲端的臨床NGS資料分析軟體。這些進步正在促進NGS技術在研究和臨床應用中的可近性、效率和普及性。

政府主導的計畫與基因組計畫：諸如印度基因組計畫、法國個人化醫療計畫和沙烏地阿拉伯人類基因組計畫等大型基因組計畫正在加速NGS技術的廣泛應用。世界各國政府都在資助基因組學研究和開發，以加強疾病診斷、個人化醫療和生物技術發展。

市場限制因子

NGS市場面臨諸多挑戰，包括發展中國家熟練人員短缺、高額投資需求以及由於定序資料量龐大而導致的資料儲存限制。此外，新興地區缺乏充分利用NGS技術的基礎設施，限制了其應用。

市場區隔

依類型劃分：市場分為產品與服務兩大類。 2026年，產品類（包括儀器和耗材）將佔市場主導地位，市佔率高達86.10%。這主要得益於產品的高使用率、持續的新產品發布以及良好的供應。由於外包業務的增加，包括定序即服務在內的服務預計將穩定成長。

依技術劃分：定序技術包括合成定序（SBS）、奈米孔定序和離子半導體定序。在 Illumina 強大的產品組合的推動下，預計到 2026 年，SBS 將佔 68.41% 的市場佔有率。奈米孔測序因其便攜性和長讀長能力，預計將快速增長。

依應用領域劃分：市場分為臨床應用與研究應用兩大類。到 2026 年，臨床應用將佔 51.96% 的市場佔有率，主要驅動因素包括腫瘤學、心血管疾病、遺傳疾病診斷和生殖醫學。研究應用預計將因大型專案和技術應用而成長。

按最終用戶劃分：到 2026 年，製藥和生物技術公司將佔 48.00% 的市場佔有率，主要驅動因素包括研究合作、藥物發現以及在研發流程中採用 NGS 技術。由於政府研究資助和基因組計劃，學術和研究機構也在擴大其應用範圍。

區域市場分析

預計北美市場規模在2025年將達到58.5億美元，並在2026年達到61.8億美元。強大的研發資金和先進的基礎設施將使其保持領先地位。亞太地區預計將呈現最高的複合年增長率，這主要得益於印度基因組計劃等舉措以及中國和日本基因組醫學的快速發展。歐洲受益於強大的醫療基礎設施和政府對基因組研究的支持。拉丁美洲以及中東和非洲預計將實現溫和成長，這得益於合作夥伴關係以及基因組學領域能力的不斷提升。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要國家/地區主要疾病盛行率（2025 年）
  • 主要國家/地區監管和報銷狀況概述
  • 主要公司新產品發布
  • 主要公司主要產業趨勢
  • 次世代定序技術進展概述
  • COVID-19 的影響市場

第五章 全球次世代定序市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依類型劃分
    • 依產品劃分
      • 設備
      • 耗材
    • 服務
  • 市場分析、洞察與預測：依技術劃分
    • 合成定序 (SBS)
    • 奈米孔定序
    • 離子半導體定序
    • 其他
  • 市場分析、洞察與預測：依應用劃分
    • 研究與應用
    • 臨床
      • 心血管
      • 腫瘤
      • 遺傳疾病
      • 生殖醫藥
  • 市場分析、洞察與預測：依最終用戶劃分
    • 製藥與生技公司
    • 學術與研究機構
    • 其他
  • 市場分析、洞察與預測：按地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美次世代定序市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲次世代定序市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第八章 亞太地區次世代定序市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲次世代定序市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章 中東與非洲次世代定序市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會
    • 南非
    • 中東和非洲其他地區

第十一章 競爭分析

  • 全球市佔率分析（2025）
  • 公司簡介
    • Illumina公司
    • 賽默飛世爾科技公司
    • F.霍夫曼-拉羅氏有限公司
    • 凱傑
    • 太平洋生物
    • 牛津奈米孔科技公司
    • 珀金埃爾默公司
    • 華大基因
Product Code: FBI101000

Growth Factors of next-generation sequencing (NGS) Market

The global next-generation sequencing (NGS) market was valued at USD 10.44 billion in 2025 and is projected to reach USD 11.79 billion in 2026, eventually growing to USD 38.34 billion by 2034, representing a CAGR of 15.88% during the forecast period. North America dominated the market in 2025 with a 56.01% share, driven by advanced research infrastructure, significant R&D investments, strong adoption of genomics in clinical and research applications, and the presence of leading players like Illumina Inc., Thermo Fisher Scientific Inc., and PacBio.

Next-generation sequencing is a revolutionary technology that enables high-throughput, scalable, and rapid DNA sequencing, transforming genomics research and clinical diagnostics. Its applications span genetic testing, non-invasive prenatal testing, oncology, infectious disease monitoring, and personalized medicine. The COVID-19 pandemic accelerated NGS adoption as the technology was used to study, monitor, and sequence the SARS-CoV-2 virus, boosting research activities and investments in vaccine development.

Key Market Drivers

Diversified Applications in Diagnostics and Research: The decreasing costs of NGS and its high accuracy have expanded its applications in diagnostics, including cancer screening, reproductive health, genetic disorder detection, and companion diagnostics. For example, Thermo Fisher Scientific and Bayer collaborated in March 2024 to develop NGS-based companion diagnostic assays, supporting clinical pipelines.

Technological Advancements and Product Innovation: Continuous innovation in instruments and consumables has enhanced sequencing speed, accuracy, and data analysis. In June 2022, PerkinElmer launched the BioQule NGS System, an automated benchtop solution, while Illumina introduced Connected Insights, a cloud-based software for clinical NGS data analysis in March 2023. These advancements increase accessibility, efficiency, and adoption across research and clinical applications.

Government Initiatives and Genome Projects: Large-scale genome projects, such as the Genome India Project, Personalized Medicine Program (France), and Saudi Human Genome Program, have accelerated NGS adoption. Governments globally are funding genomic research to enhance disease diagnosis, personalized medicine, and biotechnology development.

Market Restraints

The growth of the NGS market faces challenges such as shortage of skilled personnel in developing nations, high investment requirements, and data storage limitations due to the massive volume of sequencing data generated. Additionally, emerging regions may lack sufficient infrastructure to fully leverage NGS technologies, restraining adoption.

Market Segmentation

By Type: The market is segmented into products and services. The products segment dominated the market in 2026 with 86.10% share, including instruments and consumables, due to high usage volume, continuous product launches, and availability. Services, including sequencing as a service, are projected to grow steadily as outsourcing increases.

By Technology: Sequencing technologies include Sequencing by Synthesis (SBS), nanopore sequencing, Ion semiconductor sequencing, and others. SBS held 68.41% share in 2026, led by Illumina's strong product portfolio. Nanopore sequencing is projected to grow rapidly due to portability and long-read capabilities.

By Application: The market is segmented into clinical and research & applied. Clinical applications dominated in 2026 with 51.96% share, driven by oncology, cardiovascular, genetic disorder diagnostics, and reproductive health. Research applications are expected to grow due to large-scale projects and technological adoption.

By End-User: Pharmaceutical & biotechnology companies accounted for 48.00% share in 2026, driven by research collaborations, drug discovery, and NGS adoption in development pipelines. Academic and research institutes are also increasing adoption due to government research funding and genome projects.

Regional Insights

North America generated USD 5.85 billion in 2025 and is projected to reach USD 6.18 billion by 2026, maintaining dominance due to strong research funding and advanced infrastructure. Asia Pacific is expected to witness the highest CAGR, driven by initiatives like the Genome India Project and rapid adoption of genomic medicine in China and Japan. Europe benefits from strong healthcare infrastructure and government support for genomics research. Latin America and the Middle East & Africa are projected to witness moderate growth, supported by partnerships and capacity expansion in genomics.

Competitive Landscape

The NGS market is highly consolidated, led by Illumina Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., QIAGEN, PacBio, Oxford Nanopore Technologies, PerkinElmer, and BGI. Key strategies include product innovation, collaborations, capacity expansion, and strategic partnerships. For instance, Illumina and HaploX collaborated in 2023 to provide locally manufactured sequencing instruments in China.

Conclusion

The global NGS market is projected to experience substantial growth from 2025 to 2034, driven by declining sequencing costs, expanded clinical and research applications, genome projects, technological innovation, and government support. North America remains the largest market, while Asia Pacific is expected to grow at the fastest rate. Dominance in products, SBS technology, clinical applications, and pharmaceutical & biotechnology end-users is expected to continue. Strategic initiatives by major players, along with advancements in sequencing platforms, will drive the market to reach USD 38.34 billion by 2034, enabling improved genomic research, diagnostics, and personalized healthcare worldwide.

Segmentation By Type

  • Products
    • Instruments
    • Consumables
  • Services

By Technology

  • Sequencing By Synthesis (SBS)
  • Nanopore Sequencing
  • ION Semiconductor Sequencing
  • Others

By Application

  • Research & Applied
  • Clinical
    • Cardiovascular
    • Oncology
    • Genetic Diseases
    • Reproductive Health

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others

By Region

  • North America (By Type, Technology, Application, End-User, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Technology, Application, End-User, and Country/ Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Technology, Application, End-User, and Country/ Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of the Asia Pacific
  • Latin America (By Type, Technology, Application, End-User, and Country/ Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Technology, Application, End-User, and Country/ Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Market Scope
  • 1.2. Market Segmentation
  • 1.3. Market Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Diseases, By Key Countries, 2025
  • 4.2. Overview: Regulatory Scenario & Reimbursement Scenario, By Key Countries/Region
  • 4.3. New Product Launches, By Key Players
  • 4.4. Key Industry Developments, By Key Players
  • 4.5. Overview: Technological Advancements in Next-generation Sequencing
  • 4.6. Impact of COVID-19 on the Market

5. Global Next-generation Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Products
      • 5.1.1.1. Instruments
      • 5.1.1.2. Consumables
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Technology
    • 5.2.1. Sequencing By Synthesis (SBS)
    • 5.2.2. Nanopore Sequencing
    • 5.2.3. ION Semiconductor Sequencing
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Research & Applied
    • 5.3.2. Clinical
      • 5.3.2.1. Cardiovascular
      • 5.3.2.2. Oncology
      • 5.3.2.3. Genetic Diseases
      • 5.3.2.4. Reproductive Health
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Pharmaceutical & Biotechnology Companies
    • 5.4.2. Academic & Research Institutes
    • 5.4.3. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Next-generation Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Products
      • 6.1.1.1. Instruments
      • 6.1.1.2. Consumables
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Technology
    • 6.2.1. Sequencing By Synthesis (SBS)
    • 6.2.2. Nanopore Sequencing
    • 6.2.3. ION Semiconductor Sequencing
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Research & Applied
    • 6.3.2. Clinical
      • 6.3.2.1. Cardiovascular
      • 6.3.2.2. Oncology
      • 6.3.2.3. Genetic Diseases
      • 6.3.2.4. Reproductive Health
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Pharmaceutical & Biotechnology Companies
    • 6.4.2. Academic & Research Institutes
    • 6.4.3. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Next-generation Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Products
      • 7.1.1.1. Instruments
      • 7.1.1.2. Consumables
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Technology
    • 7.2.1. Sequencing By Synthesis (SBS)
    • 7.2.2. Nanopore Sequencing
    • 7.2.3. ION Semiconductor Sequencing
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Research & Applied
    • 7.3.2. Clinical
      • 7.3.2.1. Cardiovascular
      • 7.3.2.2. Oncology
      • 7.3.2.3. Genetic Diseases
      • 7.3.2.4. Reproductive Health
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Pharmaceutical & Biotechnology Companies
    • 7.4.2. Academic & Research Institutes
    • 7.4.3. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Next-generation Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Products
      • 8.1.1.1. Instruments
      • 8.1.1.2. Consumables
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Technology
    • 8.2.1. Sequencing By Synthesis (SBS)
    • 8.2.2. Nanopore Sequencing
    • 8.2.3. ION Semiconductor Sequencing
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Research & Applied
    • 8.3.2. Clinical
      • 8.3.2.1. Cardiovascular
      • 8.3.2.2. Oncology
      • 8.3.2.3. Genetic Diseases
      • 8.3.2.4. Reproductive Health
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Pharmaceutical & Biotechnology Companies
    • 8.4.2. Academic & Research Institutes
    • 8.4.3. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Next-generation Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Products
      • 9.1.1.1. Instruments
      • 9.1.1.2. Consumables
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Technology
    • 9.2.1. Sequencing By Synthesis (SBS)
    • 9.2.2. Nanopore Sequencing
    • 9.2.3. ION Semiconductor Sequencing
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Research & Applied
    • 9.3.2. Clinical
      • 9.3.2.1. Cardiovascular
      • 9.3.2.2. Oncology
      • 9.3.2.3. Genetic Diseases
      • 9.3.2.4. Reproductive Health
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Pharmaceutical & Biotechnology Companies
    • 9.4.2. Academic & Research Institutes
    • 9.4.3. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Next-generation Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Products
      • 10.1.1.1. Instruments
      • 10.1.1.2. Consumables
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Technology
    • 10.2.1. Sequencing By Synthesis (SBS)
    • 10.2.2. Nanopore Sequencing
    • 10.2.3. ION Semiconductor Sequencing
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Research & Applied
    • 10.3.2. Clinical
      • 10.3.2.1. Cardiovascular
      • 10.3.2.2. Oncology
      • 10.3.2.3. Genetic Diseases
      • 10.3.2.4. Reproductive Health
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Pharmaceutical & Biotechnology Companies
    • 10.4.2. Academic & Research Institutes
    • 10.4.3. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Illumina Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Thermo Fisher Scientific Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. F. Hoffmann-La Roche Ltd.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. QIAGEN
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. PacBio
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Oxford Nanopore Technologies
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Perkin Elmer, Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. BGI
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 3: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 4: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 5: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
  • Table 6: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 7: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 8: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 9: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 10: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 11: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 12: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
  • Table 13: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 14: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 15: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 16: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 17: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 18: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 19: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
  • Table 20: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 21: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 22: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 23: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 24: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 25: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 26: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
  • Table 27: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 28: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 29: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 30: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 31: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 32: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 33: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
  • Table 34: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 35: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 36: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 37: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 38: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 39: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 40: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
  • Table 41: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 42: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Next-generation Sequencing Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Next-generation Sequencing Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Next-generation Sequencing Market Value Share (%), by Technology, 2025 & 2034
  • Figure 4: Global Next-generation Sequencing Market Value Share (%), by Application, 2025 & 2034
  • Figure 5: Global Next-generation Sequencing Market Value Share (%), by End User, 2025 & 2034
  • Figure 6: Global Next-generation Sequencing Market Value (USD billion), by Region, 2025 & 2034
  • Figure 7: North America Next-generation Sequencing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 8: North America Next-generation Sequencing Market Value Share (%), by Type, 2025
  • Figure 9: North America Next-generation Sequencing Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 10: North America Next-generation Sequencing Market Value Share (%), by Technology, 2025
  • Figure 11: North America Next-generation Sequencing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 12: North America Next-generation Sequencing Market Value Share (%), by Application, 2025
  • Figure 13: North America Next-generation Sequencing Market Value (USD billion), by End User, 2025 & 2034
  • Figure 14: North America Next-generation Sequencing Market Value Share (%), by End User, 2025
  • Figure 15: North America Next-generation Sequencing Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Next-generation Sequencing Market Value Share (%), By Country, 2025
  • Figure 17: Europe Next-generation Sequencing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 18: Europe Next-generation Sequencing Market Value Share (%), by Type, 2025
  • Figure 19: Europe Next-generation Sequencing Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 20: Europe Next-generation Sequencing Market Value Share (%), by Technology, 2025
  • Figure 21: Europe Next-generation Sequencing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 22: Europe Next-generation Sequencing Market Value Share (%), by Application, 2025
  • Figure 23: Europe Next-generation Sequencing Market Value (USD billion), by End User, 2025 & 2034
  • Figure 24: Europe Next-generation Sequencing Market Value Share (%), by End User, 2025
  • Figure 25: Europe Next-generation Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Next-generation Sequencing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Next-generation Sequencing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 28: Asia Pacific Next-generation Sequencing Market Value Share (%), by Type, 2025
  • Figure 29: Asia Pacific Next-generation Sequencing Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 30: Asia Pacific Next-generation Sequencing Market Value Share (%), by Technology, 2025
  • Figure 31: Asia Pacific Next-generation Sequencing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 32: Asia Pacific Next-generation Sequencing Market Value Share (%), by Application, 2025
  • Figure 33: Asia Pacific Next-generation Sequencing Market Value (USD billion), by End User, 2025 & 2034
  • Figure 34: Asia Pacific Next-generation Sequencing Market Value Share (%), by End User, 2025
  • Figure 35: Asia Pacific Next-generation Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Next-generation Sequencing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Next-generation Sequencing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 38: Latin America Next-generation Sequencing Market Value Share (%), by Type, 2025
  • Figure 39: Latin America Next-generation Sequencing Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 40: Latin America Next-generation Sequencing Market Value Share (%), by Technology, 2025
  • Figure 41: Latin America Next-generation Sequencing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 42: Latin America Next-generation Sequencing Market Value Share (%), by Application, 2025
  • Figure 43: Latin America Next-generation Sequencing Market Value (USD billion), by End User, 2025 & 2034
  • Figure 44: Latin America Next-generation Sequencing Market Value Share (%), by End User, 2025
  • Figure 45: Latin America Next-generation Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Next-generation Sequencing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Next-generation Sequencing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 48: Middle East & Africa Next-generation Sequencing Market Value Share (%), by Type, 2025
  • Figure 49: Middle East & Africa Next-generation Sequencing Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 50: Middle East & Africa Next-generation Sequencing Market Value Share (%), by Technology, 2025
  • Figure 51: Middle East & Africa Next-generation Sequencing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 52: Middle East & Africa Next-generation Sequencing Market Value Share (%), by Application, 2025
  • Figure 53: Middle East & Africa Next-generation Sequencing Market Value (USD billion), by End User, 2025 & 2034
  • Figure 54: Middle East & Africa Next-generation Sequencing Market Value Share (%), by End User, 2025
  • Figure 55: Middle East & Africa Next-generation Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Next-generation Sequencing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Next-generation Sequencing Market Share (%), By Company, 2025